Seelos Therapeutics, Inc. presented a poster on Part 1, the open-label portion, of the study of SLS-002 at the IASR/AFSP International Summit on Suicide Research Virtual Conference.
Category Press Release
Seelos Therapeutics, Inc. presented a poster on Part 1, the open-label portion, of the study of SLS-002 at the IASR/AFSP International Summit on Suicide Research Virtual Conference.